Federal contract award

75N94025F00001

THE EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT (NICHD) CONDUCTS STUDIES FOCUSING ON CHILD HEALTH AND HUMAN DEVELOPMENT AND AS SUCH HAS GENERATED AND WILL CONTINUE TO GENERATE A COLLECTION OF HUMAN BIOSPECIMENS PER

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NICHD
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCAN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Parent award / vehicle75N94025D00002
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$309.0K
Current contract value$309.0K
Potential contract value / ceiling$1.8M
Start dateJan 22, 2025
Current end dateJan 21, 2027
Potential end dateJan 21, 2035
Latest award activityJan 21, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jan 21, 2026P00003$0NICHD: SERVICE: ADMINISTRATIVE TASK ORDER: SEVERABLE
Dec 19, 2025P00002$156.4KNICHD: SERVICE: ADMINISTRATIVE TASK ORDER: SEVERABLE
Jun 5, 2025P00001$0NICHD: SERVICE: ADMINISTRATIVE TASK ORDER: SEVERABLE
Jan 21, 20250$152.6KTHE EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT (NICHD) CONDUCTS STUDIES FOCUSING ON CHILD HEALTH AND HUMAN DEVELOPMENT AND AS SUCH HAS GENERATED AND WILL CONTINUE TO GENERATE A COLLECTION OF HUMAN BIOSPECIMENS PER

Estimated positioning window

Jan 21, 2034 – Jul 21, 2034

Recompete signal:
55/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 55/100. Available recorded signals: 50 points.

Contract end 2035-01-21 (3003 days from calculation)
+5 points
75 historical awards in this buyer and category group
+15 points
4 recorded award transactions
+10 points
Latest award action: 2026-01-21
+5 points
Parent award identifier recorded
+5 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
MAIN, TY BContactty.main@nih.gov
+1 301 827 7718
SourceApr 10, 2024
MAIN, TY BContactty.main@nih.gov
+1 301 827 7718
SourceApr 8, 2024
MAIN, TY BContactty.main@nih.gov
+1 301 827 7718
SourceMar 28, 2024
MAIN, TY BContactty.main@nih.gov
+1 301 827 7718
SourceMar 26, 2024
MAIN, TY BContactty.main@nih.gov
+1 301 827 7718
SourceMar 4, 2024
MAIN, TY BContactty.main@nih.gov
+1 301 827 7718
SourceFeb 27, 2024
WHITE, GANNON PContactgannon.white@nih.gov
+1 301 402 9178
SourceFeb 8, 2024
HARRIS, DANA LContactharrisd@nih.gov
+1 301 443 7798
SourceOct 30, 2023
HARRIS, DANA LContactharrisd@nih.gov
+1 301 443 7798
SourceOct 20, 2023

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Verify whether remaining options may extend performance beyond the current end date.
  3. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  4. Review the award scope and buyer evidence before making a bid/no-bid decision.